Seelos Therapeutics Inc (SEEL)
0.291
+0.01
(+1.89%)
USD |
NASDAQ |
Apr 26, 15:38
Seelos Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2023 | -0.8093 |
December 31, 2022 | -1.890 |
September 30, 2022 | 2.716 |
June 30, 2022 | 0.7344 |
March 31, 2022 | 0.4199 |
December 31, 2021 | 0.3301 |
September 30, 2021 | 0.00 |
June 30, 2021 | 0.0001 |
March 31, 2021 | 0.2239 |
December 31, 2020 | 3.781 |
September 30, 2020 | 0.022 |
June 30, 2020 | 0.0397 |
March 31, 2020 | 0.00 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
Date | Value |
---|---|
December 31, 2016 | -0.8848 |
September 30, 2016 | -0.9781 |
June 30, 2016 | -0.8548 |
March 31, 2016 | -1.278 |
December 31, 2015 | -0.9454 |
September 30, 2015 | -1.248 |
June 30, 2015 | -1.499 |
March 31, 2015 | 2.889 |
December 31, 2014 | 2.490 |
September 30, 2014 | 0.1003 |
June 30, 2014 | 0.0997 |
March 31, 2014 | 0.2991 |
December 31, 2013 | 0.237 |
September 30, 2013 | 0.2129 |
June 30, 2013 | 0.1857 |
March 31, 2013 | -5.573 |
December 31, 2012 | 0.5155 |
September 30, 2012 | 0.1699 |
June 30, 2012 | 0.2375 |
March 31, 2012 | 0.1983 |
December 31, 2011 | 0.8302 |
September 30, 2011 | 0.6375 |
June 30, 2011 | 0.7185 |
March 31, 2011 | 0.3482 |
December 31, 2010 | 0.3805 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.890
Minimum
Dec 2022
3.781
Maximum
Dec 2020
0.348
Average
0.011
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 5.418M |
Total Liabilities (Quarterly) | 38.93M |
Shareholders Equity (Quarterly) | -33.51M |